Jiangxi Institute of Biological Products Inc. - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by JING Ruihua, was filed 29 Jul 2026.
Jiangxi Institute of Biological Products Inc. - H Shares: what insiders have been doing
Every trade that managers of Jiangxi Institute of Biological Products Inc. - H Shares disclose to HKEX is tracked on this page. The company sits in the Health Care sector. From 22 October 2025 to 22 October 2026, the disclosure feed for Jiangxi Institute of Biological Products Inc. - H Shares logged 5 filings by 3 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 3 purchases totalling €1.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. JING Ruihua filed the largest purchase, €972k, on 29 July 2026, which represents 0.25% of the company's market value. On the buying side, the filings list 1 senior executive among the declarants.
The last purchase on record was published on 29 July 2026, which is 102 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 2 days. Until a filing is published, the market cannot know about the trade.
Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -0.8%Entry HK$0.60 · Close at T+30 HK$0.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 412,500 shares@ HK$15.4280.18% mcap39.3% of flowShareXHKGHKEX:DA20260729E00373Canonical exit: 26 Oct 2026 (T+90)
- 644,500 shares@ HK$13.500.25% mcap53.5% of flowShareXHKGHKEX:DA20260729E00370Canonical exit: 25 Oct 2026 (T+90)
- 71,000 shares@ HK$16.4930.034% mcap7.2% of flowShareXHKGHKEX:DA20260729E00375Canonical exit: 27 Oct 2026 (T+90)
- 208,562,250 sharesShareXHKGHKEX:DA20260714E00454
- 4,357,919 sharesShareXHKGHKEX:DA20260714E00459
5 of 5 declarations
About Jiangxi Institute of Biological Products Inc. - H Shares
Jiangxi Institute of Biological Products Inc. - H Shares is a company focused on the research, development, and production of biological products. It is listed on the Hong Kong stock market.
